Codexis, Inc. (CDXS) Financials

CDXS Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 149.6 million 70.3 million
2023-12-31 136.6 million 49.9 million
2023-09-30 154.5 million 62.9 million
2023-06-30 206.8 million 82.6 million

CDXS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -8.9 million ?
2023-12-31 -10.7 million 2.2 million
2023-09-30 -17.0 million 2.3 million
2023-06-30 -17.7 million 2.7 million

CDXS Net Income

No data available :(

CDXS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 86.0 million - -
2023-12-31 65.6 million - 16.0 million
2023-09-30 74.6 million - 20.0 million
2023-06-30 92.1 million - 41.0 million

CDXS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 69.9 million
2023-12-31 69.5 million
2023-09-30 69.5 million
2023-06-30 67.6 million

CDXS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 1.1 million 10.2 million - -
2023-12-31 380000 11.2 million 10.7 million 300000
2023-09-30 678000 13.7 million 12.3 million -
2023-06-30 1.6 million 17.3 million 13.4 million -

CDXS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 17.1 million 6.1 million
2023-12-31 26.6 million 4.1 million
2023-09-30 9.3 million 2.2 million
2023-06-30 21.3 million 3.2 million

CDXS

Price: $3.56

52 week price:
1.45
4.91

Earnings Per Share: -1.12 USD

P/E Ratio: -2.37

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 517700

Ebitda: -9.8 million

Market Capitalization: 276.6 million

Links: